Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Givinostat HCl
Therapeutic Area : Genetic Disease
Study Phase : Approved FDF
Recipient : Italfarmaco S.p.A
Deal Size : Undisclosed
Deal Type : Agreement
Italfarmaco Announces Exclusive Distribution Agreement with Multicare Pharma in Brazil
Details : Multicare Pharma will support the regulatory approval in Brazil and distribute Duvyzat (givinostat), Italfarmaco’s novel histone deacetylase (HDAC) inhibitor to treat Duchenne muscular dystrophy.
Product Name : Duvyzat
Product Type : Miscellaneous
Upfront Cash : Undisclosed
September 16, 2025
Lead Product(s) : Givinostat HCl
Therapeutic Area : Genetic Disease
Highest Development Status : Approved FDF
Recipient : Italfarmaco S.p.A
Deal Size : Undisclosed
Deal Type : Agreement